Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Immuron Ltd changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 3 | 7 | +4 |
| Shares | 20.4K | 95.3K | +74.9K (+367.0%) |
| Value | $42.1K | $198.2K | +$156.1K (+370.8%) |
New holders (5)
Institutions that held Immuron Ltd at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 46,577 | $96.9K | 0.00% |
| Susquehanna International Group, LLP | 39,858 | $82.9K | 0.00% |
| UBS Group AG | 2,361 | $4.91K | 0.00% |
| Advisory Services Network, LLC | 500 | $1.04K | 0.00% |
| BNP Paribas Arbitrage, SA | 100 | $208 | 0.00% |
Sold out (1)
Institutions that held Immuron Ltd at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Old Mission Capital LLC | 14,608 | $30.0K |